Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 23, 2022

Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay

Louise Guillaume ORCID logo, Virginie Chapelle, Carmen Minea and Damien Gruson

Corresponding author: Prof. Damien Gruson, Department of Clinical Biochemistry, Cliniques Universitaires St-Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium; and Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium, Phone: +32 (0)2 7646747, Fax: +32 (0)2 7646930, E-mail:
Louise Guillaume and Virginie Chapelle contributed equally to this work.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.


1. La Marca, A, Broekmans, FJ, Volpe, A, Fauser, BC, MacKlon, NS. Anti-Müllerian hormone (AMH): what do we still need to know? Hum Reprod 2009;24:2264–75. in Google Scholar PubMed

2. La Marca, A, Volpe, A. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol 2006;64:603–10. in Google Scholar PubMed

3. Victoria, M, Labrosse, J, Krief, F, Cédrin-Durnerin, I, Comtet, M, Grynberg, M. Anti Müllerian Hormone: more than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod 2019;48:19–24. in Google Scholar PubMed

4. Li, HWR, Wong, BPC, Ip, WK, Yeung, WSB, Ho, PC, Ng, EHY. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement. Hum Reprod 2016;31:2796–802. in Google Scholar PubMed

5. Gnoth, C, Schuring, AN, Friol, K, Tigges, J, Mallmann, P, Godehardt, E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod 2008;23:1359–65. in Google Scholar PubMed

6. Dewailly, D, Andersen, CY, Balen, A, Broekmans, F, Dilaver, N, Fanchin, R, et al.. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update 2014;20:370–85. in Google Scholar PubMed

7. Nelson, SM, Pastuszek, E, Kloss, G, Malinowska, I, Liss, J, Lukaszuk, A, et al.. Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays. Fertil Steril 2015;104:1016–21.e6. in Google Scholar PubMed

8. Fleming, R, Broekmans, F, Calhaz-Jorge, C, Dracea, L, Alexander, H, Nyboe Andersen, A, et al.. Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation? Reprod Biomed Online 2013;26:431–9. in Google Scholar PubMed

9. John, AS, Price, PC. Existing and emerging technologies for point-of-care testing. Clin Biochem Rev 2014;35:155–67.Search in Google Scholar

10. Ferguson, JM, Pépin, D, Duru, C, Matejtschuk, P, Donahoe, PK, Burns, CJ. Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone. Reprod Biomed Online 2018;37:631–40. in Google Scholar PubMed PubMed Central

Received: 2021-11-14
Accepted: 2022-02-26
Published Online: 2022-03-23
Published in Print: 2022-05-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow